About Sepragen
Sepragen is a company based in Hayward (United States) founded in 1987. Sepragen has raised $5 million across 3 funding rounds from investors including National Science Foundation. The company has 19 employees as of December 31, 2022. Sepragen offers products and services including QuantaSep® Systems, SuperFlo® Columns, and SepraFlo® Resins. Sepragen operates in a competitive market with competitors including ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and Reach Separations, among others.
- Headquarter Hayward, United States
- Employees 19 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sepragen Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5 M (USD)
in 3 rounds
-
Latest Funding Round
$5 M (USD), Series A
Sep 25, 2024
- Investors
-
Employee Count
19
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sepragen
Sepragen offers a comprehensive portfolio of products and services, including QuantaSep® Systems, SuperFlo® Columns, and SepraFlo® Resins.
Automated multi-use systems for cGMP purification in bioprocessing
Radial flow columns for high-throughput biological separations
Process-scale resins for efficient molecule separation in manufacturing
People of Sepragen
Unlock access to complete
Funding Insights of Sepragen
Sepragen has successfully raised a total of $5M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sepragen
Sepragen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for Sepragen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sepragen
Investment portfolio details for Sepragen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sepragen
Detailed financials for Sepragen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sepragen Comparisons
Peer comparison for Sepragen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sepragen
Sepragen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and Reach Separations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| Locked | Locked | Locked |
Chromatography technologies for protein separation and biomolecule recovery are provided.
|
|
| Locked | Locked | Locked |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| Locked | Locked | Locked |
Provider of proprietary filtration solutions for life science
|
|
| Locked | Locked | Locked |
Small molecule analysis and purification services are provided using chromatography.
|
|
| Locked | Locked | Locked |
Microchip liquid chromatography cartridges are supplied for nano-LC applications.
|
Detailed competitors of Sepragen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sepragen
Complete news archive for Sepragen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sepragen
Sepragen was founded in 1987 and raised its 1st funding round 26 years after it was founded.
Sepragen is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Sepragen is a funded company, having raised a total of $5M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Sepragen is 19.
Sepragen Corporation was founded in 1987 and is headquartered in Hayward, United States. Operations focus on the biotechnology sector, where products such as bioreactors, chromatography systems, resins, and columns are developed and manufactured. These enable large-scale separation and production of biotech drugs, nutritional products, and beverages. Radial flow chromatography columns are utilized, along with automated buffer dilution systems and disposable benchtop chromatography systems.
Sepragen's top competitors include ChromaTan, Sepax Technologies and Semba Biosciences.
Sepragen offers QuantaSep® Systems, SuperFlo® Columns, and SepraFlo® Resins.
Sepragen has 1 investor. Key investors include National Science Foundation.